Epidemiology of cardiovascular disease in patients with type 1 diabetes: European perspective

Experimental and Clinical Endocrinology and Diabetes

Volumn 122, Issue 4, 2014, Pages 208-214

  Matteucci, E ^a   Giampietro, O ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

cardiovascular disease; diabetes mellitus type 1; Europe; mortality

Indexed keywords

CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CEREBROVASCULAR DISEASE; EUROPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 1; EPIDEMIOLOGY;

CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 1; EUROPE; HUMANS;

EID: 84899526532     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0034-1367062     Document Type: Review

References (51)

1. Matsushima M., LaPorte R. E., Maruyama M. et al. Geographic variation in mortality among individuals with youth-onset diabetes mellitus across the world. DERI Mortality Study Group. Diabetes Epidemiology Research International. Diabetologia: 1997; 40 212 216 (Pubitemid 27060295)
2. Andersson D. K., Svärdsudd K. The value of death certification statistics in measuring mortality in persons with diabetes. Scand J Prim Health Care: 1994; 12 114 120 (Pubitemid 24212579)
3. Tripathi A., Rizvi A. A., Knight L. M. et al. Prevalence and impact of initial misclassification of pediatric type 1 diabetes mellitus. South Med J: 2012; 105 513 517
4. Ali Z., Levine B., Ripple M. et al. Diabetic ketoacidosis: a silent death. Am J Forensic Med Pathol: 2012; 33 189 193
5. Tattersall R. B., Gill G. V. Unexplained deaths of type 1 diabetic patients. Diabet Med: 1991; 8 49 58
6. Patterson C. C., Dahlquist G., Harjutsalo V. et al. Early mortality in EURODIAB population-based cohorts of type 1 diabetes diagnosed in childhood since 1989. Diabetologia: 2007; 50 2439 2442 (Pubitemid 350060644)
7. Secrest A. M., Becker D. J., Kelsey S. F. et al. Characterizing sudden death and dead-in-bed syndrome in Type 1 diabetes: analysis from two childhood-onset Type 1 diabetes registries. Diabet Med: 2011; 28 293 300
8. Harjutsalo V., Maric-Bilkan C., Forsblom C. et al. Impact of sex and age at onset of diabetes on mortality from ischemic heart disease in patients with type 1 diabetes. Diabetes Care: 2014; 37 144 108
9. Dahlquist G., Källén B. Mortality in childhood-onset type 1 diabetes: a population-based study. Diabetes Care: 2005; 28 2384 2387 (Pubitemid 41384281)
10. Wibell L., Nyström L., Ostman J. et al. Increased mortality in diabetes during the first 10 years of the disease. A population-based study (DISS) in Swedish adults 15-34 years old at diagnosis. J Intern Med: 2001; 249 263 270 (Pubitemid 32417789)
11. Bruno G., Cerutti F., Merletti F. et al. Piedmont Study Group for Diabetes Epidemiology Short-term mortality risk in children and young adults with type 1 diabetes: the population-based Registry of the Province of Turin, Italy. Nutr Metab Cardiovasc Dis: 2009; 19 340 344
12. Laing S. P., Swerdlow A. J., Slater S. D. et al. The British Diabetic Association Cohort Study, I: all-cause mortality in patients with insulin-treated diabetes mellitus. Diabet Med: 1999; 16 459 465
13. Laing S. P., Swerdlow A. J., Slater S. D. et al. The British Diabetic Association Cohort Study, II: cause-specific mortality in patients with insulin-treated diabetes mellitus. Diabet Med: 1999; 16 466 471
14. Skrivarhaug T., Bangstad H. J., Stene L. C. et al. Long-term mortality in a nationwide cohort of childhood-onset type 1 diabetic patients in Norway. Diabetologia: 2006; 49 298 305 (Pubitemid 43185398)
15. Soedamah-Muthu S. S., Fuller J. H., Mulnier H. E. et al. All-cause mortality rates in patients with type 1 diabetes mellitus compared with a non-diabetic population from the UK general practice research database, 1992-1999. Diabetologia: 2006; 49 660 666 (Pubitemid 43357538)
16. Soedamah-Muthu S. S., Fuller J. H., Mulnier H. E. et al. High risk of cardiovascular disease in patients with type 1 diabetes in the U.K.: a cohort study using the general practice research database. Diabetes Care: 2006; 29 798 804 (Pubitemid 44115297)
17. Harjutsalo V., Forsblom C., Groop P. H. Time trends in mortality in patients with type 1 diabetes: nationwide population based cohort study. BMJ: 2011; 343 d5364
18. Podar T., Solntsev A., Reunanen A. et al. Mortality in patients with childhood-onset type 1 diabetes in Finland, Estonia, and Lithuania: follow-up of nationwide cohorts. Diabetes Care: 2000; 23 290 294 (Pubitemid 30131732)
19. Waernbaum I., Blohmé G., Ostman J. et al. Excess mortality in incident cases of diabetes mellitus aged 15 to 34 years at diagnosis: a population-based study (DISS) in Sweden. Diabetologia: 2006; 49 653 659 (Pubitemid 43357537)
20. Allemann S., Saner C., Zwahlen M. et al. Long-term cardiovascular and non-cardiovascular mortality in women and men with type 1 and type 2 diabetes mellitus: a 30-year follow-up in Switzerland. Swiss Med Wkly: 2009; 139 576 583
21. Jorgensen M. E., Almdal T. P., Carstensen B. Time trends in mortality rates in type 1 diabetes from 2002 to 2011. Diabetologia: 2013; 56 2401 2404
22. Laing S. P., Swerdlow A. J., Carpenter L. M. et al. Mortality from cerebrovascular disease in a cohort of 23 000 patients with insulin-treated diabetes. Stroke: 2003; 34 418 421 (Pubitemid 36206341)
23. Putaala J., Curtze S., Hiltunen S. et al. Causes of death and predictors of 5-year mortality in young adults after first-ever ischemic stroke: the Helsinki Young Stroke Registry. Stroke: 2009; 40 2698 2703
24. Lindsay R. S., Little J., Jaap A. J. et al. Diabetic nephropathy is associated with an increased familial risk of stroke. Diabetes Care: 1999; 22 422 425 (Pubitemid 29106898)
25. Rossing P., Hougaard P., Borch-Johnsen K. et al. Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study. BMJ: 1996; 313 779 784 (Pubitemid 26326878)
26. Rossing P., Breum L., Major-Pedersen A. et al. Prolonged QTc interval predicts mortality in patients with Type 1 diabetes mellitus. Diabet Med: 2001; 18 199 205 (Pubitemid 32397857)
27. Mühlhauser I., Overmann H., Bender R. et al. Predictors of mortality and end-stage diabetic complications in patients with Type 1 diabetes mellitus on intensified insulin therapy. Diabet Med: 2000; 17 727 734
28. Forssas E., Manderbacka K., Arffman M. et al. Socio-economic predictors of mortality among diabetic people. Eur J Public Health: 2012; 22 305 310
29. Forssas E. H., Keskimäki I. T., Reunanen A. R. et al. Coronary heart disease among diabetic and nondiabetic people - socioeconomic differences in incidence, prognosis and mortality. J Diabetes Complications: 2008; 22 10 17
30. The Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med: 1993; 329 977 986
31. Klein B. E., Klein R., McBride P. E. et al. Cardiovascular disease, mortality, and retinal microvascular characteristics in type 1 diabetes: Wisconsin epidemiologic study of diabetic retinopathy. Arch Intern Med: 2004; 164 1917 1924 (Pubitemid 39274363)
32. Nathan D. M., Cleary P. A., Backlund J. Y. et al. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med: 2005; 353 2643 2653
33. Prince C. T., Becker D. J., Costacou T. et al. Changes in glycaemic control and risk of coronary artery disease in type 1 diabetes mellitus: findings from the Pittsburgh Epidemiology of Diabetes Complications Study (EDC). Diabetologia: 2007; 50 2280 2288 (Pubitemid 47512402)
34. Soedamah-Muthu S. S., Chaturvedi N., Witte D. R. et al. EURODIAB Prospective Complications Study Group Relationship between risk factors and mortality in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study (PCS). Diabetes Care: 2008; 31 1360 1366
35. Eeg-Olofsson K., Cederholm J., Nilsson P. M. et al. Glycemic control and cardiovascular disease in 7 454 patients with type 1 diabetes: an observational study from the Swedish National Diabetes Register (NDR). Diabetes Care: 2010; 33 1640 1646
36. Thomas M. C., Moran J., Forsblom C. et al. FinnDiane Study Group The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes. Diabetes Care: 2011; 34 861 866
37. Orchard T. J., LLoyd C. E., Maser R. E. et al. Why does diabetic autonomic neuropathy predict IDDM mortality? An analysis from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Res Clin Pract: 1996; 34 S165 S171 (Pubitemid 27062118)
38. Astrup A. S., Tarnow L., Rossing P. et al. Cardiac autonomic neuropathy predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy. Diabetes Care: 2006; 29 334 339 (Pubitemid 44106514)
39. Forsblom C., Thomas M. C., Moran J. et al. FinnDiane Study Group Serum adiponectin concentration is a positive predictor of all-cause and cardiovascular mortality in type 1 diabetes. J Intern Med: 2011; 270 346 355
40. Furfaro A. L., Sanguineti R., Storace D. et al. Metalloproteinases and advanced glycation end products: coupled navigation in atherosclerotic plaque pathophysiology? Exp Clin Endocrinol Diabetes: 2012; 120 586 590
41. Skrha J. Jr, Kalousová M., Svarcová J. et al. Relationship of soluble RAGE and RAGE ligands HMGB1 and EN-RAGE to endothelial dysfunction in type 1 and type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes: 2012; 120 277 281
42. Thomas M. C., Söderlund J., Lehto M. et al. FinnDiane Study Group Soluble receptor for AGE (RAGE) is a novel independent predictor of all-cause and cardiovascular mortality in type 1 diabetes. Diabetologia: 2011; 54 2669 2677
43. Lopes-Virella M. F., Hunt K. J., Baker N. L. et al. VADT Investigators The levels of MDA-LDL in circulating immune complexes predict myocardial infarction in the VADT study. Atherosclerosis: 2012; 224 526 531
44. Astrup A. S. Cardiovascular morbidity and mortality in diabetes mellitus: prediction and prognosis. Dan Med Bull: 2011; 58 B4152
45. Chen Y. H., Feng B., Chen Z. W. Statins for primary prevention of cardiovascular and cerebrovascular events in diabetic patients without established cardiovascular diseases: a meta-analysis. Exp Clin Endocrinol Diabetes: 2012; 120 116 120
46. Song J. W., Chung K. C. Observational studies: cohort and case-control studies. Plast Reconstr Surg: 2010; 126 2234 2242
47. Roglic G., Unwin N., Bennett P. H. et al. The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care: 2005; 28 2130 2135 (Pubitemid 41242456)
48. Boyko E. J. Progress in the estimation of mortality due to diabetes. Diabetes Care: 2005; 28 2320 2321 (Pubitemid 41242489)
49. von Elm E., Altman D. G., Egger M. et al. STROBE Initiative The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet: 2007; 370 1453 1457
50. McEwen L. N., Kim C., Haan M. et al. TRIAD Study Group Diabetes reporting as a cause of death: results from the Translating Research Into Action for Diabetes (TRIAD) study. Diabetes Care: 2006; 29 247 253 (Pubitemid 44121081)
51. Hassan Sadek N., Sadek A. R., Tahir A. et al. Evaluating tools to support a new practical classification of diabetes: excellent control may represent misdiagnosis and omission from disease registers is associated with worse control. Int J Clin Pract: 2012; 66 874 882